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SYNOPSIS A study has been made by clinical methods and by bio-assay of the effectiveness of a regime for prophylaxis against tetanus. The two principal objects of the method were to ensure that active immunization was offered to all patients who had received antitoxin and to measure the effect of the combined administration of toxoid and antitoxin.
Because of a high incidence of failure to re-attend, 63-9 % of patients requiring protection against tetanus would never have begun a course of active immunity unless toxoid had been given at the first attendance. The administration of antitoxin at the same time as the toxoid is given does not interfere with the latter's ability to provoke an immune response. A second injection of fluid toxoid produced a satisfactory immune response in 80'6 % of subjects whose first dose had been given simultaneously with antitoxin.
METHOD OF PROPHYLAXIS
We assumed that protection was necessary in all patients in whom the skin surface was breached, unless they were wounded under conditions approaching those of surgical cleanliness.
All patients were classed according to their status of immunity and of sensitivity (Table I) , and a procedure for prophylaxis was assigned to each of these classes (Table II) . No further antitoxin was given to any patient who in response to a test dose developed any general reaction such as headache, malaise, nausea, tachycardia, flush, or pallor. Eleven reactions considered severe were observed. Of these, five took the form of immediate reactions to the first test dose and all of these had been classed in group A. The other six were generalized skin reactions with pyrexia commencing between six and 14 
MATERIAL
In the five months January to May 1960, 1,352 of the patients who attended the Casualty Department were judged to need prophylaxis against tetanus. Nine hundred and sixty-four (71 %) of these were male. Their ages were between 11 months and 86 years: two-thirds were between 10 and 40 years. Eight hundred and thirtyfive (63 2%) were placed in group A, 151 (9 7%) were placed in group B, and 366 (27.1 %) were placed in group C. None qualified for group D. Thus, 986 patients (those in groups A and B) were advised to attend for further injections after six weeks and again after six months. Six hundred and twenty-nine (63-9 %) did not return for the second injection and only 114 (11-6%) returned for the full course of injections.
METHOD OF MEASURING IMMUNITY
METHOD OF SAMPLING We classed all patients according to the number of injections that they had received: group I, initial dose of antitoxin with toxoid; group II, one injection of antitoxin with toxoid and one subsequent dose of toxiod; group ILL, one injection of antitoxin with toxoid and two subsequent doses of toxoid (Table III) . We took too a control group of 21 adult volunteers who were given a single injection of fluid toxoid and who had had no previous prophylaxis of any sort against tetanus, and another control group of adults who had never had any tetanus prophylactic injections at all.
Patients were randomly selected from each group for estimation of their serum levels of antitoxin. The serum of all the volunteers was similarly examined.
MATERIAL One hundred and twenty-three specimens of serum were examined. Thirty-five patients had attended for the full course of three injections, 31 had attended Prophylaxis against tetanus: An investigation into efficiency of a method ANTIBODY LEVELS There were striking differences in the antibody levels obtained in the three clinical groups and in the control groups (Figs. 1 and 2) . The median serum titres were as follows:
Control group (one injection) . . < 0 001 u./ml. Group I .... < 0 001 u./ml. Group II .... 0 03 u./ml. Group III .... 0 3-1-0 u./ml.
In the base line control group, who had had no injections at all, there was no detectable level in any subject.
DISCUSSION
The basis of the work on active immunization was laid by Glenny and Sudmersen (1921) , who showed the value of a circulating actively produced antibody, and of the change occurring after active stimulation of the antitoxin-producing cells. This potential immunity expresses itself in the rapid and violent production of antitoxin when the sensitized organism is again exposed to the same antigen.
It was the view of the workers advising against the simultaneous administration of toxoid and antitoxin that the former would be completely neutralized by the much greater dose of antitoxin with consequent loss of antigenicity. However, the evidence for this neutralization is based on observations of antibody levels made 14 days after the injection, when, in theory, the peak titre should be reached (Barr and Sachs, 1955) . Regamey, Simon, and Wantz (1955) have shown that there is only a small difference between the serum titres obtained by giving toxoid at the same time as antitoxin and those obtained when an interval of one month separates the injections. Miller, Ryan, and Beard (1949) failed to detect any significant difference in final titres when the toxoid and antitoxin were given simultaneously but into different limbs. Many others have advocated simultaneous injection of toxoid and antitoxin (Gold and Bachers, 1943; Eckmann and Bisaz, 1956; Fisher, 1956; Eckmann, 1958; Hubner, 1958; and Klingenberg and Maresch, 1958) . Greenberg and Fleming (1950, 1951) , investigating the neutralizing effect of antitoxin in active immunization against diphtheria, found that the excess antitoxin merely delayed the maximum development of actively produced antitoxin. The same results were reported by Tasman and Huygen (1962) with tetanus antitoxin and toxoid absorbed on to aluminium phosphate. They found that the response four weeks after injection was much better when the toxoid was given one month after the antitoxin. After seven months, however, the levels were the same whether the toxoid had been given at the same time as the antitoxin or an interval had separated the two injections.
Accepting the level of 0-01 u./ml. as adequate (Scheibel, 1955; Tasman and Huygen, 1962; Bergey, Brown, and Etris, 1939) (Marvell and Parish, 1940; Bigler and Werner, 1941) . Holt (1950) first described this as a tertiary response, but Barr and Llewellyn-Jones (1951) have shown that this particularly well maintained response is characteristic of that obtained when there is a long interval between injections. In our group II (Fig. 2) there were four patients who had their second injections of toxoid after a delay of five months or more. Their response to the second dose of toxoid was on the average high (1-5, 0 3, 0-1, and 0-001 u./ml. after delays of 20, 38, 40, and 22 weeks respectively).
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